GE HealthCare (GEHC)

Nasdaq Health Care Health Care Equipment S&P 500Nasdaq-100

$82.38

-1.37 (-1.64%)

Close of Nov 06, 2026 · end-of-day data

Source: GE HealthCare's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$17.59B	$18.34B	$19.55B	$19.67B	$20.62B
Gross profit	$7.17B	$7.18B	$7.92B	$8.21B	$8.25B
Research & development	$816.00M	$1.03B	$1.21B	$1.31B	$1.26B
Selling, general & admin	$3.56B	$3.63B	$4.28B	$4.27B	$4.22B
Operating income	$2.79B	$2.52B	$2.44B	$2.62B	$2.76B
Pre-tax income	$2.88B	$2.51B	$2.36B	$2.58B	$2.77B
Income tax	$600.00M	$563.00M	$743.00M	$531.00M	$614.00M
Net income	$2.25B	$1.92B	$1.57B	$1.99B	$2.08B
EBITDA	$3.02B	$2.75B	$2.68B	$2.89B	$3.05B
EPS (basic)	$4.95	$4.22	$3.05	$4.37	$4.56
EPS (diluted)	$4.95	$4.22	$3.03	$4.34	$4.55
Diluted shares	454.00M	454.00M	458.00M	459.00M	458.00M
Gross margin	40.8%	39.1%	40.5%	41.7%	40.0%
Operating margin	15.9%	13.8%	12.5%	13.3%	13.4%
Net margin	12.8%	10.4%	8.0%	10.1%	10.1%

Balance sheet

fiscal years · USD

Fiscal year	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$561.00M	$1.44B	$2.49B	$2.87B	$4.49B
Inventory	—	$2.15B	$1.96B	$1.94B	$2.23B
Total current assets	—	$8.32B	$9.41B	$9.90B	$12.50B
Goodwill	$12.89B	$12.81B	$12.94B	$13.14B	$13.49B
Total assets	—	$27.54B	$32.45B	$33.09B	$36.91B
Total current liabilities	—	$7.19B	$8.98B	$9.55B	$9.11B
Short-term debt	—	$7.00M	$1.00B	$1.50B	$502.00M
Long-term debt	—	$8.23B	$8.44B	$7.45B	$9.49B
Total debt	—	$8.24B	$9.44B	$8.95B	$10.00B
Total liabilities	—	$17.95B	$25.14B	$24.44B	$26.31B
Shareholders' equity	$16.68B	$9.36B	$7.13B	$8.45B	$10.38B

Cash flow

fiscal years · USD

Fiscal year	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$1.61B	$2.13B	$2.10B	$1.96B	$1.99B
Capital expenditures	$248.00M	$310.00M	$387.00M	$401.00M	$482.00M
Free cash flow	$1.36B	$1.82B	$1.71B	$1.55B	$1.50B
Investing cash flow	-$1.76B	-$398.00M	-$558.00M	-$914.00M	-$1.05B
Financing cash flow	-$263.00M	-$822.00M	-$478.00M	-$573.00M	$617.00M
Dividends paid	$0	$0	$41.00M	$55.00M	$64.00M
Share buybacks	—	—	$0	$0	$200.00M
Stock-based compensation	$76.00M	$67.00M	$114.00M	$125.00M	$130.00M
Depreciation & amortization	$225.00M	$228.00M	$248.00M	$268.00M	$287.00M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$5.21B	$4.65B	$4.84B	$4.86B	$5.32B	$4.78B	$5.01B	$5.14B	$5.70B	$5.13B	$5.29B	$5.51B
Gross profit	$2.16B	$1.90B	$2.00B	$2.03B	$2.27B	$2.01B	$1.99B	$1.99B	$2.26B	$1.98B	$2.18B	$2.22B
Research & development	$315.00M	$324.00M	$327.00M	$316.00M	$344.00M	$344.00M	$302.00M	$292.00M	$323.00M	$345.00M	$323.00M	$320.00M
Selling, general & admin	$1.15B	$1.04B	$1.07B	$1.03B	$1.13B	$1.04B	$1.03B	$1.04B	$1.11B	$1.12B	$1.12B	$1.10B
Operating income	$689.00M	$540.00M	$608.00M	$676.00M	$801.00M	$629.00M	$654.00M	$653.00M	$827.00M	$515.00M	$739.00M	$805.00M
Pre-tax income	$609.00M	$512.00M	$578.00M	$658.00M	$834.00M	$692.00M	$613.00M	$643.00M	$821.00M	$505.00M	$693.00M	$752.00M
Income tax	$193.00M	$124.00M	$143.00M	$168.00M	$96.00M	$104.00M	$113.00M	$179.00M	$219.00M	$94.00M	$119.00M	$129.00M
Net income	$403.00M	$374.00M	$428.00M	$470.00M	$721.00M	$564.00M	$486.00M	$446.00M	$589.00M	$389.00M	$561.00M	$615.00M
EBITDA	$749.00M	$608.00M	$677.00M	$742.00M	$866.00M	$695.00M	$727.00M	$728.00M	$901.00M	$593.00M	$815.00M	$886.00M
EPS (basic)	$0.89	$0.82	$0.94	$1.03	$1.58	$1.23	$1.06	$0.98	$1.29	$0.85	$1.24	$1.36
EPS (diluted)	$0.88	$0.81	$0.93	$1.02	$1.57	$1.23	$1.06	$0.98	$1.29	$0.85	$1.24	$1.36
Diluted shares	0	459.00M	459.00M	459.00M	0	459.00M	458.00M	457.00M	0	457.00M	454.00M	453.00M
Gross margin	41.4%	40.9%	41.4%	41.7%	42.8%	42.1%	39.6%	38.7%	39.7%	38.5%	41.2%	40.3%
Operating margin	13.2%	11.6%	12.6%	13.9%	15.1%	13.2%	13.1%	12.7%	14.5%	10.0%	14.0%	14.6%
Net margin	7.7%	8.0%	8.8%	9.7%	13.6%	11.8%	9.7%	8.7%	10.3%	7.6%	10.6%	11.2%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$2.49B	$2.55B	$2.00B	$3.55B	$2.87B	$2.45B	$3.74B	$4.00B	$4.49B	$2.26B	$2.08B	$2.83B
Inventory	$1.96B	$1.99B	$2.02B	$2.12B	$1.94B	$2.16B	$2.28B	$2.30B	$2.23B	$2.35B	$2.48B	$2.63B
Total current assets	$9.41B	$9.37B	$8.81B	$10.64B	$9.90B	$9.73B	$11.31B	$11.89B	$12.50B	$10.43B	$10.50B	$11.49B
Goodwill	$12.94B	$12.93B	$13.12B	$13.14B	$13.14B	$13.37B	$13.42B	$13.44B	$13.49B	$15.06B	$15.10B	$15.14B
Total assets	$32.45B	$32.21B	$31.85B	$33.85B	$33.09B	$33.59B	$35.50B	$36.13B	$36.91B	$37.12B	$37.25B	$38.37B
Total current liabilities	$8.98B	$8.86B	$8.32B	$8.67B	$9.55B	$9.97B	$9.75B	$10.07B	$9.11B	$8.53B	$8.30B	$8.81B
Short-term debt	$1.00B	$1.00B	$1.00B	$1.00B	$1.50B	$2.00B	$2.00B	$2.00B	$502.00M	$2.00M	$2.00M	$2.00M
Long-term debt	$8.44B	$8.25B	$8.23B	$9.31B	$7.45B	$6.76B	$8.27B	$8.28B	$9.49B	$10.13B	$10.09B	$9.97B
Total debt	$9.44B	$9.25B	$9.24B	$10.31B	$8.95B	$8.76B	$10.27B	$10.28B	$10.00B	$10.13B	$10.09B	$9.97B
Total liabilities	$25.14B	$24.61B	$23.86B	$25.34B	$24.44B	$24.17B	$25.55B	$25.91B	$26.31B	$26.23B	$26.03B	$26.51B
Shareholders' equity	$7.13B	$7.41B	$7.80B	$8.32B	$8.45B	$9.19B	$9.71B	$9.99B	$10.38B	$10.67B	$10.97B	$11.61B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$1.05B	$419.00M	-$119.00M	—	$913.00M	$250.00M	$94.00M	$593.00M	$1.05B	$290.00M	$168.00M	$907.00M
Capital expenditures	$94.00M	$145.00M	$64.00M	$90.00M	$102.00M	$152.00M	$86.00M	$110.00M	$134.00M	$178.00M	$100.00M	$114.00M
Free cash flow	$956.00M	$274.00M	-$183.00M	—	$811.00M	$98.00M	$8.00M	$483.00M	$916.00M	$112.00M	$68.00M	$793.00M
Investing cash flow	-$88.00M	-$188.00M	-$349.00M	-$137.00M	-$240.00M	-$407.00M	-$223.00M	-$148.00M	-$269.00M	-$2.50B	-$115.00M	-$111.00M
Financing cash flow	-$900.00M	-$153.00M	-$57.00M	$914.00M	-$1.28B	-$286.00M	$1.36B	-$165.00M	-$293.00M	$21.00M	-$236.00M	-$40.00M
Dividends paid	$13.00M	$14.00M	$14.00M	$13.00M	$14.00M	$16.00M	$16.00M	$16.00M	$16.00M	$16.00M	$16.00M	$16.00M
Share buybacks	—	—	—	$0	$0	$0	$100.00M	$100.00M	$0	$100.00M	$200.00M	$0
Stock-based compensation	$33.00M	$34.00M	$36.00M	$22.00M	$33.00M	$22.00M	$34.00M	$38.00M	$36.00M	$35.00M	$45.00M	$36.00M
Depreciation & amortization	$60.00M	$68.00M	$69.00M	$66.00M	$65.00M	$66.00M	$73.00M	$75.00M	$74.00M	$78.00M	$76.00M	$81.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.